exclusives

Ignite It
6 min read • April 11, 2018

Florida Rep. Carlos Smith On How His LGBTQ Identity Led Him To Cannabis, Gun Control Advocacy

Ignite It
3 min read • April 5, 2018

An Inside Look At High Times’ $7M Acquisition Of Green Rush Daily, A Marijuana News Company

Ignite It
4 min read • March 15, 2018

4-Time NBA Champion John Salley Talks About His Cannabis Ventures

Ignite It
4 min read • March 7, 2018

Wonder Women Of Weed: Amanda Ostrowitz, From Federal Reserve Bank Regulator To Cannabis Compliance Entrepreneur

Ignite It
7 min read • February 6, 2018

Cannabis Businesses Invest In The Midwest As Michigan’s New Medical Marijuana Laws Take Effect

Ignite It
5 min read • February 2, 2018

Football And Weed: Former NFL Players Weigh In On Why Many Are Getting Involved With CBD Companies

Ignite It
3 min read • January 31, 2018

A New Marijuana Stock Index Debuts Today: These Are The 30 Cannabis Companies In It

Ignite It
5 min read • January 25, 2018

Why GW Pharma’s Epidiolex Results Could Shape The Future Of Cannabis-Based Therapeutics

Ignite It
1 min read • January 25, 2018

420 Investor Alan Brochstein Notes While He Sold Out Of His Positions In More Speculative Cannabis Names Following Rescinding Of Cole Memo, He ‘kept 5 or 6% exposure to GW Pharma’

Ignite It
1 min read • January 25, 2018

420 Investor Alan Brochstein Responds To Publication Of GW Pharma’s Epidiolex Study Results In Lancet: ‘Results aren’t really news. What’s actually more relevant is the fact that peer-reviewed medical journals are publishing cannabis-related results.’

Ignite It
6 min read • January 18, 2018

Wonder Women Of Weed: Yvonne DeLaRosa Green, The Latina Revolutionizing Conscious Commerce With Cannabis

Ignite It
4 min read • January 11, 2018

Even Alabama Republicans Disagree With Attorney General Jeff Sessions’ Views On Marijuana Legalization

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.